A detailed history of Bank Of America Corp transactions in Biogen Inc. stock. As of the latest transaction made, Bank Of America Corp holds 658,151 shares of BIIB stock, worth $96.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
658,151
Previous 488,346 34.77%
Holding current value
$96.4 Million
Previous $113 Million 12.69%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $32.1 Million - $40.2 Million
169,805 Added 34.77%
658,151 $128 Million
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $8.52 Million - $10.6 Million
44,724 Added 10.08%
488,346 $113 Million
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $3.61 Million - $4.56 Million
17,048 Added 4.0%
443,622 $95.7 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $22.3 Million - $26.9 Million
100,395 Added 30.78%
426,574 $110 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $44 Million - $50.8 Million
-159,731 Reduced 32.87%
326,179 $92.9 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $2.68 Million - $3.05 Million
-10,427 Reduced 2.1%
485,910 $135 Million
Q4 2022

Feb 10, 2023

SELL
$252.44 - $306.72 $18.3 Million - $22.2 Million
-72,464 Reduced 12.74%
496,337 $137 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $26.5 Million - $36.5 Million
-136,063 Reduced 19.3%
568,801 $152 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $3.05 Million - $3.63 Million
16,280 Added 2.36%
704,864 $144 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $43.1 Million - $54.3 Million
-222,317 Reduced 24.41%
688,584 $145 Million
Q4 2021

Feb 08, 2022

BUY
$223.92 - $287.77 $37.6 Million - $48.4 Million
168,052 Added 22.62%
910,901 $219 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $14.3 Million - $18.7 Million
50,598 Added 7.31%
742,849 $210 Million
Q2 2021

Sep 13, 2021

BUY
$259.0 - $414.71 $179 Million - $287 Million
692,251 New
692,251 $240 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.